Sign In
Buy BTAI
$1.26
-0.0400 (-3.08%)
At Close: Jun 23, 2026
BioXcel Therapeutics stock plummets as 3Q earnings fall short of expectations
10:41am, Tuesday, 14'th Nov 2023
BioXcel Therapeutics Inc (NASDAQ:BTAI) shares fell almost 35% after it reported a revenue miss and greater than forecast loss for the third quarter. The New Haven, Connecticut-based biopharmaceutical
5 Most Active Penny Stocks Today & Why They're Moving Now
02:11pm, Wednesday, 01'st Nov 2023
Penny stocks are the wild west of the stock market. Fast-paced, unpredictable, and laden with potential treasures.
Penny Stocks To Buy Today? 4 To Watch Now
02:18pm, Tuesday, 31'st Oct 2023
Ready to dive into the volatile world of penny stocks? You've got your work cut out for yourself if this is your first foray into the stock market.
4 Penny Stocks To Watch Today With Big News, Time To Buy?
12:09pm, Monday, 30'th Oct 2023
Trading penny stocks can be a risky endeavor, but having access to quality news and information can help mitigate some of that risk. As an investor or trader, it's critical to understand how news even
3 Penny Stocks To Buy For Under $5, Are They Worth It?
03:06pm, Thursday, 26'th Oct 2023
Penny stocks are defined as stocks trading for under $5. They typically include start-up or emerging-growth stage companies starting from the grassroots.
5 Hot Penny Stocks To Watch In The Stock Market Today
09:19am, Wednesday, 25'th Oct 2023
Whether you're looking for the best penny stocks to buy, the most active stocks today, or just trying to plan out your next long-term investment, understanding things like stock market news and events
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?
09:18am, Wednesday, 25'th Oct 2023
BioXcel Therapeutics (NASDAQ: BTAI ) stock is rocketing higher on Wednesday after the biopharmaceutical company announced results from an audit of its Tranquility II clinical trial. According to a pre
BioXcel Therapeutics shares pop after audit of Alzheimer's trial data
08:44am, Wednesday, 25'th Oct 2023
Shares of BioXcel Therapeutics Inc. BTAI, +0.86% jumped more than 40% premarket on Wednesday after the company said an independent audit of Alzheimer's trial data found no issues impacting the data's
Why Shares of BioXcel Therapeutics Fell This Week
05:35pm, Thursday, 28'th Sep 2023
The company has one marketed treatment -- Igalmi, which reduces agitation in patients with bipolar disorder or schizophrenia. The most advanced candidate in BioXcel's pipeline is BXCL501, which aims t
Why BioXcel Therapeutics Stock Flopped Again Today
05:43pm, Tuesday, 15'th Aug 2023
The biotech takes another hit following its earnings release on Monday. Several analysts became notably more bullish on its prospects.
3 Biotech Stocks to Sell in August Before They Crash and Burn
12:44pm, Monday, 14'th Aug 2023
Investors who've dipped their toe into the waters of biotech stocks know that the chances of these stocks crashing and burning is certainly higher than with most sectors. Failure is incredibly common
Why BioXcel Therapeutics Stock Is Getting Crushed Today
12:01pm, Monday, 14'th Aug 2023
BioXcel announced Q2 results and a major strategic shift this morning. The biotech specialist has halted plans for Phase 2 clinical trials that were important to the bull thesis on its stock.
Why Is BioXcel Therapeutics (BTAI) Stock Down 46% Today?
10:33am, Monday, 14'th Aug 2023
BioXcel Therapeutics (NASDAQ: BTAI ) stock is taking a beating on Monday after the biopharmaceutical company announced layoffs. This has BioXcel Therapeutics cutting over 50% of its workforce.
Biotech Stock Plummets After Halving Workforce
10:26am, Monday, 14'th Aug 2023
BioXcel Therapeutics Inc (NASDAQ:BTAI) is plummeting, last seen down 46.3% to trade at $3.98 after its second-quarter earnings report.
BioXcel Therapeutics stock plummets as it cuts jobs in half to focus on AI-powered innovation
09:59am, Monday, 14'th Aug 2023
BioXcel Therapeutics Inc (NASDAQ:BTAI) stock opened close to 45% lower as trading kicked off in New York on Monday after it revealed it would be wielding the axe across its business. Around half of Bi
